Top HealthTech Companies in Europe

Oxford Nanopore (@nanopore): is a sequencing company (spun out of the University of Oxford) valued at around $4,6 billion in London IPO. Oxford Nanopore is offering a technology to analyse any length of native DNA or RNA, and it's the only sequencing tech company to enable real-time analysis, in fully scalable formats--from pocket to population scale. But Nanopore goes beyond sequencing, since ML learning algorithms can be used to extract unknown biology information hidden in the Nanopore sequencing data. On the report of a Financial Times article, the pandemic put Nanopore on the map since its patented technology (MinION the world's first portable pocket-sized sequencing device) was used in identifying and tracking the spread of Covid variants in 85 countries, by sequencing about 18% of all coronavirus genomes globally. In fact, Oxford Nanopore made a gross profit of £26.9m in the first half of 2021 and is now competing with Illumina in a $7 billion market for DNA sequencing, dominated so far by Illumina.